Nanolive has released it’s next generation immunotherapy solution: the LIVE T Cell Assay. This real-time digital assay combines label-free live cell imaging and AI-powered analysis to deliver continuous, multiparametric data – ranging from T cell activation to target cell interactions and killing.
Watch the product release, where we showcase the versatility of the LIVE T Cell Assay through case studies featuring CAR-T and bispecific antibody screening, highlighting the assay’s ability to characterize immunotherapeutic specificity, robustness, and efficacy, as well as its value across different stages of preclinical research and development.
Read our latest news
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.
Online walkthrough – Replace fragmented assays: one workflow for cell therapy assessment
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.
Ferroptosis and CAR-T Engineering: Research from MIT
Discover live cell imaging data highlights from a seminar at MIT and register for Nanolive’s latest data walkthrough for liquid tumor analysis.